DUDE...VYROLOGIX...with multiple indications is no

DUDE...VYROLOGIX...with multiple indications is not just interested in SURVIVING...and someone with 200,000 shares and reading my recent posts on returns from SRPT..should be mindful of ANY negative slant they introduce to anyone who might be researching the Molecule and it's benefits. I could care less what other companies had to do to Survive...staying on the NYSE might have been necessary for them to avoid delisting..has NO bearing on where we are and we plan to go.